Movement Disorders Journal Podcasts 2012-2015
By Unknown
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Unknown
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 7
Reviews: 0
Episodes: 577
Description
Movement Disorders Journal Podcasts 2012-2015
| Episode | Date |
|---|---|
|
Progressive Retinal Structure Abnormalities in Multiple System Atrophy
|
Dec 21, 2015 |
|
Multiple Resting-State Networks Are Associated With Tremors and Cognitive Features in Essential Tremor
|
Dec 21, 2015 |
|
The Motor Inhibition System in Parkinson’s Disease With Levodopa-Induced Dyskinesias
|
Dec 21, 2015 |
|
Volume 30 Issue 14 (2015)
|
Dec 21, 2015 |
|
Factor Analysis of the Hospital Anxiety and Depression Scale Among a Huntington’s Disease Population
|
Dec 21, 2015 |
|
Functional Assessment and Quality of Life in Essential Tremor With Bilateral or Unilateral DBS and Focused Ultrasound Thalamotomy
|
Dec 21, 2015 |
|
Is Dominant-Side Onset Associated With a Better Motor Compensation in Parkinson’s Disease?
|
Dec 21, 2015 |
|
Cerebral Perfusion and Cortical Thickness Indicate Cortical Involvement in Mild Parkinson’s Disease
|
Dec 21, 2015 |
|
Clinicopathological Characteristics of Freezing of Gait in Autopsy-Confirmed Parkinson’s Disease
|
Dec 21, 2015 |
|
Diffusion Imaging of Nigral Alterations in Early Parkinson’s Disease With Dopaminergic Deficits
|
Dec 21, 2015 |
|
Volume 30 Issue 13 (2015)
|
Dec 07, 2015 |
|
Light pigmentation phenotype is correlated with increased substantia nigra echogenicity
|
Dec 07, 2015 |
|
Sleep aspects on video-polysomnography in LRRK2 mutation carriers
|
Dec 07, 2015 |
|
The Severity and Pattern of Autonomic Dysfunction in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
|
Dec 07, 2015 |
|
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers
|
Dec 07, 2015 |
|
Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
|
Dec 07, 2015 |
|
Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12
|
Dec 07, 2015 |
|
Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy
|
Dec 07, 2015 |
|
Altered brain network centrality in depressed Parkinson's disease patients
|
Dec 07, 2015 |
|
Loss of EEG Network Efficiency Is Related to Cognitive Impairment in Dementia With Lewy Bodies
|
Dec 07, 2015 |
|
Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives
|
Dec 07, 2015 |
|
Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats
|
Dec 07, 2015 |
|
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity
|
Dec 07, 2015 |
|
Volume 30 Issue 12 (2015)
|
Nov 10, 2015 |
|
A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease
|
Nov 10, 2015 |
|
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study
|
Nov 10, 2015 |
|
Premotor–motor excitability is altered in dopa-responsive dystonia
|
Nov 10, 2015 |
|
A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography
|
Nov 10, 2015 |
|
Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy
|
Nov 10, 2015 |
|
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
|
Nov 10, 2015 |
|
Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD
|
Nov 10, 2015 |
|
Essential and aging-related tremor: Differences of central control
|
Nov 10, 2015 |
|
Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease
|
Nov 10, 2015 |
|
Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients
|
Nov 10, 2015 |
|
Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial
|
Nov 10, 2015 |
|
Handling missing values in the MDS-UPDRS
|
Nov 10, 2015 |
|
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation
|
Nov 10, 2015 |
|
Quantitative assessment of brain iron by R2* relaxometry in patients with cervical dystonia
|
Nov 04, 2015 |
|
Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial
|
Nov 04, 2015 |
|
Volume 30 Issue 10 (2015)
|
Nov 04, 2015 |
|
Probable RBD and association with neurodegenerative disease markers: A population-based study
|
Nov 04, 2015 |
|
Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome
|
Nov 04, 2015 |
|
REM sleep behavior disorder and neuropathology in Parkinson's disease
|
Nov 04, 2015 |
|
Appendectomy may delay Parkinson's disease Onset
|
Nov 04, 2015 |
|
Longitudinal study of the substantia nigra in Parkinson's disease: A high-field 1H-MR spectroscopy imaging study
|
Nov 04, 2015 |
|
Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2
|
Nov 04, 2015 |
|
Modifications of resting state networks in spinocerebellar ataxia type 2
|
Nov 04, 2015 |
|
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study
|
Nov 04, 2015 |
|
Colonic bacterial composition in Parkinson's disease
|
Nov 04, 2015 |
|
Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease
|
Nov 04, 2015 |
|
Patterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies
|
Nov 04, 2015 |
|
Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study
|
Nov 04, 2015 |
|
Tremor in the elderly: Essential and aging-related tremor
|
Nov 04, 2015 |
|
Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET
|
Sep 18, 2015 |
|
Volume 30 Issue 9 (2015)
|
Sep 18, 2015 |
|
Global cognitive scores do not predict outcome after subthalamic nucleus deep brain stimulation
|
Sep 18, 2015 |
|
Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease
|
Sep 18, 2015 |
|
A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam
|
Sep 18, 2015 |
|
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease
|
Sep 18, 2015 |
|
Sensorimotor processing for balance in spinocerebellar ataxia type 6
|
Sep 18, 2015 |
|
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy
|
Sep 18, 2015 |
|
Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease
|
Sep 18, 2015 |
|
Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease
|
Sep 18, 2015 |
|
Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease
|
Sep 18, 2015 |
|
Objective assessment of postural stability in Parkinson's disease using mobile technology
|
Sep 18, 2015 |
|
Volume 30 Issue 8 (2015)
|
Aug 27, 2015 |
|
GDNF gene is associated with Tourette syndrome in a family study
|
Aug 27, 2015 |
|
T1ρ imaging in premanifest Huntington's disease reveals changes associated with disease progression
|
Aug 27, 2015 |
|
Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?
|
Aug 27, 2015 |
|
Freezing of gait in Parkinson's disease is related to impaired motor switching during stepping
|
Aug 27, 2015 |
|
High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry
|
Aug 27, 2015 |
|
Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism
|
Aug 27, 2015 |
|
In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial
|
Aug 27, 2015 |
|
Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum
|
Aug 27, 2015 |
|
Manganese transport disorder: Novel SLC30A10 mutations and early phenotypes
|
Jul 28, 2015 |
|
Volume 30 Issue 7 (2015)
|
Jul 28, 2015 |
|
Plasma Oligomeric Alpha-Synuclein Is Associated With Glucocerebrosidase Activity in Gaucher Disease
|
Jul 28, 2015 |
|
Pallidal activity in myoclonus dystonia correlates with motor signs
|
Jul 28, 2015 |
|
Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: A comparative study
|
Jul 28, 2015 |
|
Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits
|
Jul 28, 2015 |
|
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene
|
Jul 28, 2015 |
|
Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease
|
Jul 28, 2015 |
|
Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
|
Jul 28, 2015 |
|
Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
|
Jul 28, 2015 |
|
Minimal change multiple system atrophy: An aggressive variant?
|
Jul 28, 2015 |
|
Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease
|
Jul 28, 2015 |
|
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
|
Jul 28, 2015 |
|
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
|
Jul 28, 2015 |
|
Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study
|
Jul 28, 2015 |
|
Volume 30, Issue 6 (2015)
|
Jun 10, 2015 |
|
Diminished event-related cortical arousals and altered heart rate response in Parkinson's disease
|
Jun 10, 2015 |
|
Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking
|
Jun 10, 2015 |
|
Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease
|
Jun 10, 2015 |
|
Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia
|
Jun 10, 2015 |
|
Genetic risk and age in Parkinson's disease: Continuum not stratum
|
Jun 10, 2015 |
|
Impact of Parkinson's disease risk loci on age at onset
|
Jun 10, 2015 |
|
Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study
|
Jun 10, 2015 |
|
H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?
|
Jun 10, 2015 |
|
Low-variance RNAs identify Parkinson's disease molecular signature in blood
|
Jun 10, 2015 |
|
Somatosensory temporal discrimination in essential tremor and isolated head and voice tremors
|
Jun 10, 2015 |
|
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias
|
Jun 10, 2015 |
|
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype
|
Jun 10, 2015 |
|
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
|
Jun 10, 2015 |
|
Volume 30 Issue 5 (2015)
|
May 01, 2015 |
|
Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease
|
May 01, 2015 |
|
Entacapone and prostate cancer risk in patients with Parkinson's disease
|
May 01, 2015 |
|
Relationship of age of onset and family history in Parkinson's disease
|
May 01, 2015 |
|
Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders
|
May 01, 2015 |
|
International validation of a behavioral scale in Parkinson's disease without dementia
|
May 01, 2015 |
|
Incidence and prevalence of Parkinson's disease among Navajo people living in the Navajo nation
|
May 01, 2015 |
|
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease
|
May 01, 2015 |
|
Resting-state frontostriatal functional connectivity in Parkinson's disease–related apathy
|
May 01, 2015 |
|
Altered structure of cortical sulci in Gilles de la Tourette syndrome: Further support for abnormal brain development
|
May 01, 2015 |
|
In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7
|
May 01, 2015 |
|
Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)
|
May 01, 2015 |
|
Orthostatic hypotension in Parkinson's disease: How much you fall or how low you go?
|
May 01, 2015 |
|
Volume 30 Issue 4 (2015)
|
Apr 10, 2015 |
|
Selective changes of ocular vestibular myogenic potentials in Parkinson's disease
|
Apr 10, 2015 |
|
Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS
|
Apr 10, 2015 |
|
Genetic variability of the retromer cargo recognition complex in parkinsonism
|
Apr 10, 2015 |
|
Microstructural changes in white matter associated with freezing of gait in Parkinson's disease
|
Apr 10, 2015 |
|
Is the Parkinson anxiety scale comparable across raters?
|
Apr 10, 2015 |
|
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
|
Apr 10, 2015 |
|
Vitamin D from different sources is inversely associated with Parkinson disease
|
Apr 10, 2015 |
|
Familial aggregation of Parkinson's disease in the Faroe Islands
|
Apr 10, 2015 |
|
A population-based study on combined markers for early Parkinson's disease
|
Apr 10, 2015 |
|
In vivo gastric detection of α-synuclein inclusions in Parkinson's disease
|
Apr 10, 2015 |
|
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
|
Apr 10, 2015 |
|
Volume 30 Issue 3 (2015)
|
Mar 17, 2015 |
|
A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease
|
Mar 17, 2015 |
|
Aberrant cortical associative plasticity associated with severe adult Tourette syndrome
|
Mar 17, 2015 |
|
RELN rare variants in myoclonus-dystonia
|
Mar 17, 2015 |
|
Lower urinary tract function in dementia with Lewy bodies (DLB)
|
Mar 17, 2015 |
|
Chorea due to diabetic hyperglycemia and uremia: Distinct clinical and imaging features
|
Mar 17, 2015 |
|
GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
|
Mar 17, 2015 |
|
Diagnosing PD-MCI by MDS task force criteria: How many and which neuropsychological tests?
|
Mar 17, 2015 |
|
Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers
|
Mar 17, 2015 |
|
Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration
|
Mar 17, 2015 |
|
The significance of motor (A)symmetry in Parkinson's disease
|
Mar 17, 2015 |
|
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease
|
Mar 17, 2015 |
|
Progression of gait dysfunction in incident Parkinson's disease: Impact of medication and phenotype
|
Mar 17, 2015 |
|
Gut microbiota are related to Parkinson's disease and clinical phenotype
|
Mar 17, 2015 |
|
Basal ganglia network by constrained spherical deconvolution: A possible cortico-pallidal pathway?
|
Mar 17, 2015 |
|
Volume 30 Issue 2 (2015)
|
Feb 23, 2015 |
|
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study
|
Feb 23, 2015 |
|
Clinical markers for identifying cholinergic deficits in Parkinson's disease
|
Feb 23, 2015 |
|
DNAJC13 genetic variants in parkinsonism
|
Feb 23, 2015 |
|
Mortality in Parkinson's disease: A 38-year follow-up study
|
Feb 23, 2015 |
|
Changes in motor cortical excitability in patients with Sydenham's chorea
|
Feb 23, 2015 |
|
Motor phenotype of LRRK2-associated Parkinson's disease: A tunisian longitudinal study
|
Feb 23, 2015 |
|
Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume
|
Feb 23, 2015 |
|
The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study)
|
Feb 23, 2015 |
|
Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease
|
Feb 23, 2015 |
|
Coenzyme Q10 and spinocerebellar ataxias
|
Feb 23, 2015 |
|
Population prevalence of Tourette syndrome: A systematic review and meta-analysis
|
Feb 23, 2015 |
|
Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: A double-blind, randomized study
|
Feb 23, 2015 |
|
Increased intracortical inhibition in hyperglycemic hemichorea-hemiballism
|
Feb 23, 2015 |
|
Special Issue: Levodopa: 50 Years of a Revolutionary Drug for Parkinson Disease
|
Feb 02, 2015 |
|
Clinical spectrum of levodopa-induced complications
|
Feb 02, 2015 |
|
Novel Formulations and Modes of Delivery of Levodopa
|
Feb 02, 2015 |
|
Improving levodopa therapy for Parkinson’s disease: The development of enzyme inhibitors
|
Feb 02, 2015 |
|
Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
|
Feb 02, 2015 |
|
Central pharmacokinetics of levodopa: Lessons from imaging studies
|
Feb 02, 2015 |
|
Presynaptic effects of levodopa and their possible role in dyskinesia
|
Feb 02, 2015 |
|
Behavioral effects of levodopa
|
Feb 02, 2015 |
|
Four pioneers of L-dopa treatment
|
Feb 02, 2015 |
|
Effects of levodopa on regional cerebral metabolism and blood flow
|
Feb 02, 2015 |
|
Levodopa: Effect on cell death and the natural history of Parkinson's disease
|
Feb 02, 2015 |
|
The medical treatment of Parkinson's disease from James Parkinson to George Cotzias
|
Feb 02, 2015 |
|
Volume 29 Issue 14 (2014)
|
Dec 12, 2014 |
|
Families with Wilson's disease in subsequent generations: Clinical and genetic analysis
|
Dec 12, 2014 |
|
Lack of validation of variants associated with cervical dystonia risk: A GWAS replication study
|
Dec 12, 2014 |
|
Patients with scans without evidence of dopaminergic deficit: A long-term follow-up study
|
Dec 12, 2014 |
|
Subthalamic stimulation improves motor function but not home and neighborhood mobility
|
Dec 12, 2014 |
|
Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease
|
Dec 12, 2014 |
|
Conversion between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 scores in Parkinson's disease
|
Dec 12, 2014 |
|
Apathy in untreated early-stage Parkinson's disease: Relationship with other non-motor symptoms
|
Dec 12, 2014 |
|
Validation of CT-MRI fusion for intraoperative assessment of stereotactic accuracy in DBS surgery
|
Dec 12, 2014 |
|
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder
|
Dec 12, 2014 |
|
Weight gain following subthalamic nucleus deep brain stimulation: A PET study
|
Dec 12, 2014 |
|
Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
|
Dec 12, 2014 |
|
The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases
|
Dec 12, 2014 |
|
Primary familial brain calcification: Genetic analysis and clinical spectrum
|
Nov 12, 2014 |
|
Volume 29 Issue 13 (2014)
|
Nov 12, 2014 |
|
Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism
|
Nov 12, 2014 |
|
Coordinated reset neuromodulation for Parkinson's disease: Proof-of-concept study
|
Nov 12, 2014 |
|
Cerebellar abnormalities in Huntington's disease: A role in motor and psychiatric impairment?
|
Nov 12, 2014 |
|
Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites
|
Nov 12, 2014 |
|
Increased LINGO1 in the cerebellum of essential tremor patients
|
Nov 12, 2014 |
|
Formulations of hormone therapy and risk of Parkinson's disease
|
Nov 12, 2014 |
|
Dietary fat intake and risk for Parkinson's disease
|
Nov 12, 2014 |
|
Mortality in Parkinson's disease: A systematic review and meta-analysis
|
Nov 12, 2014 |
|
DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro
|
Nov 12, 2014 |
|
Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: Evidence from a meta-analysis
|
Nov 12, 2014 |
|
Volume 29 Issue 12 (2014)
|
Oct 28, 2014 |
|
Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease
|
Oct 28, 2014 |
|
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families
|
Oct 28, 2014 |
|
Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: Flow-mediated dilation study
|
Oct 28, 2014 |
|
Dopaminergic agents and nutritional status in Parkinson's disease
|
Oct 28, 2014 |
|
Retinal Pathology detected by optical coherence tomography in an animal model of Parkinson's disease
|
Oct 28, 2014 |
|
Action inhibition in Tourette syndrome
|
Oct 28, 2014 |
|
Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies
|
Oct 28, 2014 |
|
Cortical and brainstem plasticity in Tourette syndrome and obsessive-compulsive disorder
|
Oct 28, 2014 |
|
Variability in interval production is due to timing-dependent deficits in Huntington's disease
|
Oct 28, 2014 |
|
Plasma melatonin is reduced in Huntington's disease
|
Oct 28, 2014 |
|
DYT16 revisited: Exome sequencing identifies PRKRA mutations in a European dystonia family
|
Oct 28, 2014 |
|
Cortical thinning associated with mild cognitive impairment in Parkinson's disease
|
Oct 28, 2014 |
|
Pallidal gap junctions-triggers of synchrony in Parkinson's disease?
|
Oct 28, 2014 |
|
Volume 29 Issue 11 (2014)
|
Sep 19, 2014 |
|
Stem cells for cell replacement therapy: A therapeutic strategy for HD?
|
Sep 19, 2014 |
|
Huntingtin-lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing
|
Sep 19, 2014 |
|
Targets for future clinical trials in Huntington's disease: What's in the pipeline?
|
Sep 19, 2014 |
|
Magnetic resonance imaging striatal volumes: A biomarker for clinical trials in Huntington's disease
|
Sep 19, 2014 |
|
Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches
|
Sep 19, 2014 |
|
Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?
|
Sep 19, 2014 |
|
Mind the gap: Models in multiple species needed for therapeutic development in Huntington's disease
|
Sep 19, 2014 |
|
Preclinical models: Needed in translation? A Pro/Con debate
|
Sep 19, 2014 |
|
Metabolism in HD: Still a relevant mechanism?
|
Sep 19, 2014 |
|
Animal models of Huntington's disease for translation to the clinic: Best practices
|
Sep 19, 2014 |
|
Genetic modifiers of Huntington's disease
|
Sep 19, 2014 |
|
Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction
|
Sep 19, 2014 |
|
Onset of Huntington's disease: Can it be purely cognitive?
|
Sep 19, 2014 |
|
Flt3 ligand does not differentiate between Parkinsonian disorders
|
Sep 18, 2014 |
|
An enzyme-linked immunosorbent assay for detection of botulinum toxin-antibodies
|
Sep 18, 2014 |
|
Individual and joint prevalence of three nonmotor symptoms of PD in the US general population
|
Sep 18, 2014 |
|
The Huntington's disease dysphagia scale
|
Sep 18, 2014 |
|
Thin-slice T2 MRI imaging predicts vascular pathology in hemifacial spasm: A case-control study
|
Sep 18, 2014 |
|
Language impairment in cerebellar ataxia
|
Sep 18, 2014 |
|
Cerebellar stimulation fails to modulate motor cortex plasticity in writing dystonia
|
Sep 18, 2014 |
|
Altered corticomotor-cerebellar integrity in young ataxia telangiectasia patients
|
Sep 18, 2014 |
|
HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease
|
Sep 18, 2014 |
|
High-frequency oscillations in Parkinson's disease: Spatial distribution and clinical relevance
|
Sep 18, 2014 |
|
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
|
Sep 18, 2014 |
|
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance
|
Sep 18, 2014 |
|
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing
|
Sep 18, 2014 |
|
Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
|
Sep 18, 2014 |
|
Volume 29 Issue 10 (2014)
|
Sep 18, 2014 |
|
Sensory tricks and brain excitability in cervical dystonia: A transcranial magnetic stimulation study
|
Aug 26, 2014 |
|
Volume 29 Issue 9 (2014)
|
Aug 26, 2014 |
|
Magnetic resonance support vector machine discriminates essential tremor with rest tremor from tremor-dominant Parkinson disease
|
Aug 26, 2014 |
|
Study of medication-free children with Tourette syndrome do not show imaging abnormalities
|
Aug 26, 2014 |
|
Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease
|
Aug 26, 2014 |
|
Suprathreshold odor intensity perception in early-stage Parkinson's disease
|
Aug 26, 2014 |
|
A Novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy
|
Aug 26, 2014 |
|
Screening of mutations in GNAL in sporadic dystonia patients
|
Aug 26, 2014 |
|
De novo mutation in the GNAL gene causing seemingly sporadic dystonia in a Serbian patient
|
Aug 26, 2014 |
|
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers
|
Aug 26, 2014 |
|
Dystonia and tremor secondary to thalamic infarction successfully treated with thalamotomy of the ventralis intermedius nucleus
|
Aug 26, 2014 |
|
Prefrontal seizures manifesting as motor stereotypies
|
Aug 26, 2014 |
|
Peptidoglycan recognition protein genes and risk of Parkinson's disease
|
Aug 26, 2014 |
|
Cardiac stress test is normal in pre-motor Parkinson's disease
|
Aug 26, 2014 |
|
Photoreceptor layer thinning in idiopathic Parkinson's disease
|
Aug 26, 2014 |
|
Absent movement-related cortical potentials in children with primary motor stereotypies
|
Aug 26, 2014 |
|
What's special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study
|
Aug 26, 2014 |
|
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model
|
Aug 26, 2014 |
|
Volume 27 Issue 14 (December 2012)
|
Jul 29, 2014 |
|
The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale
|
Jul 28, 2014 |
|
Volume 29 Issue 8 (2014)
|
Jul 28, 2014 |
|
BDNF Val66Met polymorphism in primary adult-onset dystonia: A case-control study and meta-analysis
|
Jul 28, 2014 |
|
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
|
Jul 28, 2014 |
|
Combined occurrence of a novel TOR1A and a THAP1 mutation in primary dystonia
|
Jul 28, 2014 |
|
Transcranial direct current stimulation for treatment of freezing of gait: A cross-over study
|
Jul 28, 2014 |
|
History of smoking and olfaction in Parkinson's disease
|
Jul 28, 2014 |
|
Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations
|
Jul 28, 2014 |
|
Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation
|
Jul 28, 2014 |
|
Prospective study of obesity, hypertension, high cholesterol, and risk of restless legs syndrome
|
Jul 28, 2014 |
|
Alpha-synuclein repeat variants and survival in Parkinson's disease
|
Jul 28, 2014 |
|
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
|
Jul 28, 2014 |
|
Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders
|
Jul 28, 2014 |
|
Volume 29 Issue 7 (2014)
|
Jul 08, 2014 |
|
Deep brain stimulation in the ventrolateral thalamus/subthalamic area in dystonia with head tremor
|
Jul 08, 2014 |
|
The effect of deep brain stimulation randomized by site on balance in Parkinson's disease
|
Jul 08, 2014 |
|
Onset latency of segmental dystonia after deep brain stimulation cessation: A randomized, double-blind crossover trial
|
Jul 08, 2014 |
|
HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia
|
Jul 08, 2014 |
|
Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia
|
Jul 08, 2014 |
|
The phenotypic spectrum of DYT24 due to ANO3 mutations
|
Jul 08, 2014 |
|
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus?
|
Jul 08, 2014 |
|
Pramipexole reverses Parkinson's disease-related motivational deficits in rats
|
Jul 08, 2014 |
|
Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease
|
Jul 08, 2014 |
|
Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis
|
Jul 08, 2014 |
|
Female reproductive factors, menopausal hormone use, and Parkinson's disease
|
Jul 08, 2014 |
|
Neuropathological features of multiple system atrophy with cognitive impairment
|
Jul 08, 2014 |
|
Volume 29 Issue 6 (2014)
|
Jun 17, 2014 |
|
Temporal discrimination, a cervical dystonia endophenotype: Penetrance and functional correlates
|
Jun 17, 2014 |
|
Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites
|
Jun 17, 2014 |
|
Abnormal dorsal premotor–motor inhibition in writer's cramp
|
Jun 17, 2014 |
|
Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease
|
Jun 17, 2014 |
|
Does abnormal interhemispheric inhibition play a role in mirror dystonia?
|
Jun 17, 2014 |
|
Supratentorial and infratentorial damage in spinocerebellar ataxia 2: A diffusion-weighted MRI study
|
Jun 17, 2014 |
|
Evaluation of mild cognitive impairment subtypes in Parkinson's disease
|
Jun 17, 2014 |
|
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2
|
Jun 17, 2014 |
|
The source of the memory impairment in Parkinson's disease: Acquisition versus retrieval
|
Jun 17, 2014 |
|
Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire
|
Jun 17, 2014 |
|
A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study
|
Jun 17, 2014 |
|
The clinical spectrum of laryngeal dystonia includes dystonic cough: Observations of a large series
|
Jun 17, 2014 |
|
Cognition in movement disorders: Where can we hope to be in 10 years?
|
May 27, 2014 |
|
Cognition in corticobasal syndrome and progressive supranuclear palsy: A review
|
May 27, 2014 |
|
Cognitive impairment and dementia in Parkinson's disease: Practical issues and management
|
May 27, 2014 |
|
The neurobiological basis of cognitive impairment in Parkinson's disease
|
May 23, 2014 |
|
Volume 29 Issue 5 (2014)
|
May 23, 2014 |
|
Cognitive impairment in “Other” movement disorders: Hidden defects and valuable clues
|
May 23, 2014 |
|
The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation
|
May 23, 2014 |
|
Psychiatric issues in cognitive impairment
|
May 23, 2014 |
|
Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
|
May 23, 2014 |
|
The spectrum of cognitive impairment in Lewy body diseases
|
May 23, 2014 |
|
What can biomarkers tell us about cognition in Parkinson's disease?
|
May 23, 2014 |
|
The tools of the trade: A state of the art 'How to Assess Cognition' in the patient with Parkinson's disease
|
May 23, 2014 |
|
Volume 29 Issue 4 (2014)
|
May 16, 2014 |
|
A randomized controlled trial of patient-reported outcomes with tai chi exercise in Parkinson's disease
|
May 16, 2014 |
|
Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease
|
May 16, 2014 |
|
Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
|
May 16, 2014 |
|
Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease
|
May 16, 2014 |
|
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
|
May 16, 2014 |
|
Reduced cortical plasticity and GABAergic modulation in essential tremor
|
May 16, 2014 |
|
Essential tremor is not associated with cerebellar Purkinje cell loss
|
May 16, 2014 |
|
Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease
|
May 16, 2014 |
|
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
|
May 16, 2014 |
|
Rate of decline in progressive supranuclear palsy
|
May 16, 2014 |
|
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
|
May 16, 2014 |
|
Volume 27 Issue 1 (2012)
|
Apr 29, 2014 |
|
Trial designs used to study neuroprotective therapy in Parkinson’s disease
|
Apr 24, 2014 |
|
Biomarkers for trials of neuroprotection in Parkinson’s disease
|
Apr 24, 2014 |
|
Trophic factor gene therapy for Parkinson’s disease
|
Apr 24, 2014 |
|
New synaptic and molecular targets for neuroprotection in Parkinson’s disease
|
Apr 24, 2014 |
|
Animal models of Parkinson’s disease: limits and relevance to neuroprotection studies
|
Apr 24, 2014 |
|
Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder?
|
Apr 24, 2014 |
|
Neuronal vulnerability, pathogenesis, and Parkinson’s disease
|
Apr 24, 2014 |
|
Pathogenesis of Parkinson’s disease
|
Apr 24, 2014 |
|
The genetics of Parkinson’s disease: progress and therapeutic implications
|
Apr 24, 2014 |
|
Parkinson’s disease: evidence for environmental risk factors
|
Apr 24, 2014 |
|
Obstacles to the development of a neuroprotective therapy for Parkinson’s disease
|
Apr 24, 2014 |
|
Motor signs in the prodromal phase of Parkinson's disease
|
Apr 23, 2014 |
|
Defining at-risk populations for Parkinson's disease: Lessons from ongoing studies
|
Apr 23, 2014 |
|
The significance of defining preclinical or prodromal Parkinson's disease
|
Apr 23, 2014 |
|
Biochemical premotor biomarkers for Parkinson's disease
|
Apr 23, 2014 |
|
Prerequisites to launch neuroprotective trials in Parkinson's disease: An industry perspective
|
Apr 23, 2014 |
|
Neuroimaging: Current role in detecting pre-motor Parkinson's disease
|
Apr 23, 2014 |
|
Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease
|
Apr 23, 2014 |
|
Premotor Parkinson's disease: Concepts and definitions
|
Apr 23, 2014 |
|
Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression
|
Mar 12, 2014 |
|
Low-frequency subthalamic nucleus stimulation in Parkinson's disease: A randomized clinical trial
|
Mar 12, 2014 |
|
Magnetic resonance support vector machine discriminates between Parkinson's disease and progressive supranuclear palsy
|
Mar 12, 2014 |
|
Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel
|
Mar 12, 2014 |
|
Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial
|
Mar 12, 2014 |
|
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease
|
Mar 12, 2014 |
|
Subthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease
|
Mar 12, 2014 |
|
Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6
|
Mar 12, 2014 |
|
Brain SPECT in Sydenham's chorea in remission
|
Mar 12, 2014 |
|
Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease
|
Mar 12, 2014 |
|
Effects of deep brain stimulation frequency on bradykinesia of Parkinson's disease
|
Mar 12, 2014 |
|
Pathology and sensitivity of current clinical criteria in corticobasal syndrome
|
Mar 12, 2014 |
|
Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
|
Mar 12, 2014 |
|
Ramsay Hunt Syndrome: Clinical Characterization of Progressive Myoclonus Ataxia Caused by GOSR2 Mutation
|
Feb 14, 2014 |
|
Retinal Nerve Fiber Layer Thickness and Visual Hallucinations in Parkinson's Disease
|
Feb 14, 2014 |
|
Impaired Force Control in Writer's Cramp Showing a Bilateral Deficit in Sensorimotor Integration
|
Feb 14, 2014 |
|
Fluctuations in Cognition and Alertness Vary Independently in Dementia With Lewy Bodies
|
Feb 14, 2014 |
|
Primary Motor Cortex Long-Term Plasticity in Multiple System Atrophy
|
Feb 14, 2014 |
|
Rare Sequence Variants in ANO and GNAL in a Primary Torsion Dystonia Series and Controls
|
Feb 14, 2014 |
|
I Finally See What You See: Parkinson's Disease Visual Hallucinations Captured With Functional Neuroimaging
|
Feb 14, 2014 |
|
Development of a Prediction Formula of Parkinson's Disease Severity by Optical Coherence Tomography
|
Feb 14, 2014 |
|
Double-Blind Study of the Actively Transported Levodopa Prodrug XP21279 in Parkinson's Disease
|
Feb 14, 2014 |
|
Long-Term Efficacy and Safety of Fluphenazine in Patients With Tourette Syndrome
|
Feb 14, 2014 |
|
Cortical Gyrification Reductions and Subcortical Atrophy in Parkinson's Disease
|
Feb 14, 2014 |
|
Gray Matter Atrophy and Freezing of Gait in Parkinson's Disease: Is the Evidence Black-on-White?
|
Feb 14, 2014 |
|
Multisource Ascertainment of Huntington's Disease in Canada: Prevalence and Population at Risk
|
Feb 14, 2014 |
|
Herpes Simplex Encephalitis Relapse With Chorea Is Associated With Autoantibodies to N-Methyl-D-Aspartate Receptor or Dopamine-2 Receptor
|
Feb 14, 2014 |
|
N-Methyl-D-Aspartate Receptor Antibodies in Post-Herpes Simplex Virus Encephalitis Neurological Relapse
|
Feb 14, 2014 |
|
Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease
|
Jan 22, 2014 |
|
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice
|
Jan 22, 2014 |
|
Defining optimal cutoff scores for cognitive impairment using the Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease
|
Jan 22, 2014 |
|
The Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments
|
Jan 22, 2014 |
|
Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia
|
Jan 22, 2014 |
|
The unified Huntington's disease rating scale for advanced patients: Validation and follow-up study
|
Jan 22, 2014 |
|
Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease
|
Jan 22, 2014 |
|
Assessing apathy in everyday clinical practice with the short-form Lille Apathy Rating Scale
|
Jan 22, 2014 |
|
A systematic review and meta-analysis of clinical variables used in Huntington's disease research
|
Jan 22, 2014 |
|
Parkinson's disease phenotype in Ashkenazi Jews with and without LRRK2G2019S mutations
|
Jan 22, 2014 |
|
Persistent figure-eight and side-to-side head shaking is a marker for rhombencephalosynapsis
|
Jan 22, 2014 |
|
Effects of rasagiline on olfactory function in patients with Parkinson's disease
|
Jan 22, 2014 |
|
Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay
|
Jan 22, 2014 |
|
Subtle gait changes in patients with REM sleep behavior disorder
|
Dec 16, 2013 |
|
Subthalamus deep brain stimulation for primary dystonia patients: A long-term follow-up study
|
Dec 16, 2013 |
|
Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease
|
Dec 16, 2013 |
|
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor
|
Dec 16, 2013 |
|
Analysis of genome-wide association study-linked loci in Parkinson's disease of Mainland China
|
Dec 16, 2013 |
|
Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging
|
Dec 16, 2013 |
|
Clinical diagnosis of propriospinal myoclonus is unreliable: An electrophysiologic study
|
Dec 16, 2013 |
|
Pallidal stimulation for cervical dystonia does not correct abnormal temporal discrimination
|
Dec 16, 2013 |
|
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
|
Dec 16, 2013 |
|
Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
|
Dec 16, 2013 |
|
Dementia in Parkinson's disease: Usefulness of the pill questionnaire
|
Dec 16, 2013 |
|
The glial marker YKL-40 is decreased in synucleinopathies
|
Dec 16, 2013 |
|
Task-specific tremor in violinists: Evidence of coactivation in the 3 to 8 Hz frequency range
|
Dec 16, 2013 |
|
Quantification of cerebellar hemispheric purkinje cell linear density: 32 ET cases versus 16 controls
|
Dec 16, 2013 |
|
Specific Splice Variants Are Associated With Parkinson's Disease
|
Nov 25, 2013 |
|
Fall Risk and Gait in Parkinson's Disease: The Role of the LRRK2 G2019S Mutation
|
Nov 25, 2013 |
|
Altered inhibitory modulation of somatosensory cortices in paroxysmal kinesigenic dyskinesia
|
Nov 25, 2013 |
|
Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
|
Nov 25, 2013 |
|
Disruption of Visual and Motor Connectivity in Spinocerebellar Ataxia Type 7
|
Nov 25, 2013 |
|
Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's Disease
|
Nov 25, 2013 |
|
Short Sleep Duration Heralds Essential Tremor: A Prospective, Population-Based Study
|
Nov 25, 2013 |
|
Unified Huntington's Disease Rating Scale for Advanced Patients: Validation and Follow-Up Study
|
Nov 25, 2013 |
|
Sensorimotor Adaptation of Speech in Parkinson's Disease
|
Nov 25, 2013 |
|
Cortical and Subcortical Brain Atrophy in Parkinson's Disease With Visual Hallucination
|
Nov 25, 2013 |
|
Genetic Variability Related to Serum Uric Acid Concentration and Risk of Parkinson's Disease
|
Nov 25, 2013 |
|
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit
|
Nov 25, 2013 |
|
Acute Complications of Movement Disorders Surgery: Effects of Age and Comorbidities
|
Nov 25, 2013 |
|
Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia
|
Nov 25, 2013 |
|
Characterizing Freezing of Gait in Parkinson's Disease: Models of an Episodic Phenomenon
|
Oct 30, 2013 |
|
Classification of Gait Disturbances: Distinguishing Between Continuous and Episodic Changes
|
Oct 30, 2013 |
|
Effects of Exercise on Mobility in People With Parkinson's
|
Oct 30, 2013 |
|
Framework for Understanding Balance Dysfunction in Parkinson's Disease
|
Oct 30, 2013 |
|
Imaging: What Can it Tell Us About Parkinsonian Gait?
|
Oct 30, 2013 |
|
Dynamic Control of Posture Across Locomotor Tasks
|
Oct 30, 2013 |
|
Virtual Reality and Motor Imagery: Promising Tools for Assessment and Therapy in Parkinson's disease
|
Oct 30, 2013 |
|
Objective Biomarkers of Balance and Gait for Parkinson's Disease Using Body-worn Sensors
|
Oct 30, 2013 |
|
Clinical Syndromes: Parkinsonian Gait
|
Oct 30, 2013 |
|
Higher-Level Gait Disorders: An Open Frontier
|
Oct 30, 2013 |
|
Neurophysiology of Gait: From the Spinal Cord to the Frontal Lobe
|
Oct 30, 2013 |
|
Emerging Therapies for Gait Disability and Balance Impairment: Promises and Pitfalls
|
Oct 30, 2013 |
|
Moving Forward on Gait Measurement: Toward a More Refined Approach
|
Oct 30, 2013 |
|
Deep Brain Stimulation for Gait and Postural Symptoms in Parkinson's Disease
|
Oct 30, 2013 |
|
Gait Ataxia-Specific Cerebellar Influences and Their Rehabilitation
|
Oct 30, 2013 |
|
Cognitive Contributions to Gait and Falls: Evidence and Implications
|
Oct 30, 2013 |
|
Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment
|
Oct 02, 2013 |
|
Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet
|
Oct 02, 2013 |
|
Progressive cognitive dysfunction in spinocerebellar ataxia type 3
|
Oct 02, 2013 |
|
Rivastigmine is associated with restoration of left frontal brain activity in Parkinson's disease
|
Oct 02, 2013 |
|
Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease
|
Oct 02, 2013 |
|
Lack of polysomnographic Non-REM sleep changes in early Parkinson's disease
|
Oct 02, 2013 |
|
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study
|
Oct 02, 2013 |
|
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies
|
Oct 02, 2013 |
|
A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
|
Oct 02, 2013 |
|
Sustained Relief of Generalized Dystonia Despite Prolonged Interruption of Deep Brain Stimulation
|
Oct 02, 2013 |
|
The central oscillatory network of orthostatic tremor
|
Oct 02, 2013 |
|
Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration
|
Oct 02, 2013 |
|
Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
|
Oct 02, 2013 |
|
Predictive factors of outcome in primary cervical dystonia following pallidal deep brain stimulation
|
Oct 02, 2013 |
|
Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
|
Oct 02, 2013 |
|
The Babinski-2 sign in hemifacial spasm
|
Sep 13, 2013 |
|
Clinical and posturographic correlates of falling in Parkinson's disease
|
Sep 13, 2013 |
|
Effect of expectancy and personality on cortical excitability in Parkinson's disease
|
Sep 13, 2013 |
|
Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder
|
Sep 13, 2013 |
|
Head injury and risk of Parkinson disease: A systematic review and meta-analysis
|
Sep 13, 2013 |
|
The role of small intestinal bacterial overgrowth in Parkinson's disease
|
Sep 13, 2013 |
|
Short latency afferent inhibition: A biomarker for mild cognitive impairment in Parkinson's disease?
|
Sep 13, 2013 |
|
Impact of placebo assignment in clinical trials of tic disorders
|
Sep 13, 2013 |
|
Bilateral pallidal stimulation for Wilson's disease
|
Sep 13, 2013 |
|
Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implications
|
Sep 13, 2013 |
|
Ocular motor characteristics of different subtypes of spinocerebellar ataxia: Distinguishing features
|
Sep 13, 2013 |
|
A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease
|
Sep 13, 2013 |
|
Familial psychogenic movement disorders
|
Sep 13, 2013 |
|
Dystonia rating scales: Critique and recommendations
|
Aug 23, 2013 |
|
Primary dystonia: Moribund or viable
|
Aug 23, 2013 |
|
Engineering animal models of dystonia
|
Aug 23, 2013 |
|
What's new in surgical treatment for dystonia?
|
Aug 23, 2013 |
|
Phenomenology and classification of dystonia: A consensus update
|
Aug 23, 2013 |
|
Assessment of patients with isolated or combined dystonia: An update on dystonia syndromes
|
Aug 23, 2013 |
|
Psychiatric co-morbidities in dystonia: Emerging concepts
|
Aug 23, 2013 |
|
Emerging concepts in the physiological basis of dystonia
|
Aug 23, 2013 |
|
The focal dystonias: Current views and challenges for future research
|
Aug 23, 2013 |
|
Genetics of dystonia: What's known? What's new? What's next?
|
Aug 23, 2013 |
|
Emerging common molecular pathways for primary dystonia
|
Aug 23, 2013 |
|
Animal models for dystonia
|
Aug 23, 2013 |
|
The anatomical basis of dystonia: Current view using neuroimaging
|
Aug 23, 2013 |
|
Medical treatment of dystonia
|
Aug 23, 2013 |
|
Special concerns in defining, studying, and treating dystonia in children
|
Aug 23, 2013 |
|
Study of the Antidyskinetic Effect of Eltoprazine in Animal Models of Levodopa-Induced Dyskinesia
|
Aug 09, 2013 |
|
Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency
|
Aug 09, 2013 |
|
Modeling trajectories of regional volume loss in progressive supranuclear palsy
|
Aug 09, 2013 |
|
Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease
|
Aug 09, 2013 |
|
Adenosine A2A receptor antagonist istradefylline reduces daily off time in Parkinson's disease
|
Aug 09, 2013 |
|
Action-effect binding is decreased in motor conversion disorder: Implications for sense of agency
|
Aug 09, 2013 |
|
The relationship between balance control and vitamin D in Parkinson's disease-a pilot study
|
Aug 09, 2013 |
|
Selective executive dysfunction but intact risky decision-making in early Huntington's disease
|
Aug 09, 2013 |
|
Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease
|
Aug 09, 2013 |
|
Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease
|
Aug 09, 2013 |
|
High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity
|
Aug 09, 2013 |
|
Levodopa infusion does not decrease the onset of abnormal involuntary movements in Parkinsonian rats
|
Aug 09, 2013 |
|
Plasma urate in REM sleep behavior disorder
|
Aug 09, 2013 |
|
Improving memory in Parkinson's disease: A healthy brain ageing cognitive training program
|
Aug 09, 2013 |
|
Pilot study of H2 therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial
|
Jun 26, 2013 |
|
Relationship between proprioception at the knee joint and gait ataxia in HSAN III
|
Jun 26, 2013 |
|
Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study
|
Jun 26, 2013 |
|
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: A reappraisal of genetic testing criteria
|
Jun 26, 2013 |
|
Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
|
Jun 26, 2013 |
|
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
|
Jun 26, 2013 |
|
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness
|
Jun 26, 2013 |
|
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
|
Jun 26, 2013 |
|
Movement disorders in adult patients with classical galactosemia
|
Jun 26, 2013 |
|
The syndrome of deafness-dystonia: Clinical and genetic heterogeneity
|
Jun 26, 2013 |
|
White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations
|
Jun 26, 2013 |
|
The inferior olivary nucleus: A postmortem study of essential tremor cases versus controls
|
Jun 26, 2013 |
|
Is TOR1A a risk factor in adult-onset primary torsion dystonia?
|
Jun 26, 2013 |
|
Three simple clinical tests to accurately predict falls in people with Parkinson's disease
|
Jun 03, 2013 |
|
Response inhibition in motor conversion disorder
|
Jun 03, 2013 |
|
X-linked Dystonia-Parkinsonism manifesting in a female patient due to atypical turner syndrome
|
Jun 03, 2013 |
|
How to identify tremor dominant and postural instability/gait difficulty groups with The Movement Disorder Society Unified Parkinson's Disease Rating Scale: Comparison with the Unified Parkinson's Disease Rating Scale
|
Jun 03, 2013 |
|
Head-pelvis coupling is increased during turning in patients with Parkinson's disease and freezing of gait
|
Jun 03, 2013 |
|
Prevalence and clinical classification of tremor in elderly - A community-based survey in Brazil
|
Jun 03, 2013 |
|
Corticomuscular coherence in asymptomatic first-degree relatives of patients with essential tremor
|
Jun 03, 2013 |
|
Effectiveness of Multidisciplinary Care for Parkinson's Disease: A Randomized, Controlled Trial
|
Jun 03, 2013 |
|
Mild Depressive Symptoms Are Associated with Gait Impairment in Early Parkinson's Disease
|
Jun 03, 2013 |
|
Effects of Deep Brain Stimulation in Dyskinetic Cerebral Palsy: A Meta-analysis
|
Jun 03, 2013 |
|
Validation of a screening battery to predict driving fitness in people with Parkinson's disease
|
Jun 03, 2013 |
|
Measuring mild cognitive impairment in patients with Parkinson's disease
|
Jun 03, 2013 |
|
Levodopa improves motor deficits but can further disrupt cognition in a macaque parkinson model
|
Jun 03, 2013 |
|
Failure of explicit movement control in patients with functional motor symptoms
|
May 20, 2013 |
|
Topography of dyskinesias and torticollis evoked by inhibition of substantia nigra pars reticulata
|
May 20, 2013 |
|
Long-term course of substantia nigra hyperechogenicity in Parkinson's disease
|
May 20, 2013 |
|
Protective stepping response in Parkinsonian patients and the effect of vibrotactile feedback
|
May 20, 2013 |
|
Longitudinal Study of Levodopa in Parkinson's Disease: Effects of the Advanced Disease Phase
|
May 20, 2013 |
|
The role of SCARB2 as susceptibility factor in Parkinson's disease
|
May 20, 2013 |
|
Stance instability in spinocerebellar ataxia type 6
|
May 20, 2013 |
|
Long-term depression-like plasticity of the blink reflex for the treatment of blepharospasm
|
May 20, 2013 |
|
Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia
|
May 20, 2013 |
|
Validation of parkinsonian disease-related metabolic brain patterns
|
May 20, 2013 |
|
Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy
|
May 20, 2013 |
|
Functional movement disorders are not uncommon in the elderly
|
May 20, 2013 |
|
The spectrum of movement disorders in children with anti-NMDA receptor encephalitis
|
May 20, 2013 |
|
Ocular Tremor in Parkinson's Disease Is Due to Head Oscillation
|
May 20, 2013 |
|
Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone
|
May 20, 2013 |
|
Unimpaired postprandial pancreatic polypeptide secretion in Parkinson's disease and REM sleep behavior disorder
|
May 20, 2013 |
|
Levodopa does not change cerebral vasoreactivity in Parkinson's disease
|
May 20, 2013 |
|
An economic model of Parkinson's disease: Implications for slowing progression in the United States
|
Apr 05, 2013 |
|
The current and projected economic burden of Parkinson's disease in the United States
|
Apr 05, 2013 |
|
Prospective cohort study of impulse control disorders in Parkinson's disease
|
Apr 05, 2013 |
|
Sensory tricks in primary cervical dystonia depend on visuotactile temporal discrimination
|
Apr 05, 2013 |
|
Which Dyskinesia Scale Best Detects Treatment Response?
|
Apr 05, 2013 |
|
Caffeine consumption and risk of dyskinesia in CALM-PD
|
Apr 05, 2013 |
|
Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease
|
Apr 05, 2013 |
|
Hip Fractures in People With Idiopathic Parkinson's Disease: Incidence and Outcomes
|
Apr 05, 2013 |
|
Latah: An Indonesian Startle Syndrome
|
Apr 05, 2013 |
|
Bladder dysfunction in a transgenic mouse model of multiple system atrophy
|
Apr 05, 2013 |
|
Lewy Body Pathology in a Patient with a Homozygous Parkin Deletion
|
Apr 05, 2013 |
|
Disrupted Cerebellar Connectivity Reduces Whole-Brain Network Efficiency in Multiple System Atrophy
|
Apr 05, 2013 |
|
Atypical Parkinsonism due to a D202N Gerstmann-Straussler-Scheinker prion protein mutation: First in vivo diagnosed case
|
Feb 25, 2013 |
|
PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation
|
Feb 25, 2013 |
|
Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
|
Feb 25, 2013 |
|
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
|
Feb 25, 2013 |
|
Common data elements for clinical research in Friedreich's ataxia
|
Feb 25, 2013 |
|
Cumulative exposure to lead and cognition in persons with Parkinson's disease
|
Feb 25, 2013 |
|
Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES)
|
Feb 25, 2013 |
|
Analysis of CYP2D6 genotype and response to tetrabenazine
|
Feb 25, 2013 |
|
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease
|
Feb 25, 2013 |
|
The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach
|
Feb 25, 2013 |
|
β-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy
|
Feb 25, 2013 |
|
Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study
|
Feb 25, 2013 |
|
Sonographic abnormality of the substantia nigra in melanoma patients
|
Feb 25, 2013 |
|
Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study
|
Feb 25, 2013 |
|
Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function
|
Feb 25, 2013 |
|
Trial Designs Used to Study Neuroprotective Therapy in Parkinson's Disease
|
Jan 30, 2013 |
|
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
|
Jan 30, 2013 |
|
Trophic Factor Gene Therapy for Parkinson's Disease
|
Jan 30, 2013 |
|
Pathogenesis of Parkinson's Disease
|
Jan 30, 2013 |
|
Neuronal Vulnerability, Pathogenesis, and Parkinson's Disease
|
Jan 30, 2013 |
|
New Synaptic and Molecular Targets for Neuroprotection in Parkinson's Disease
|
Jan 30, 2013 |
|
Biomarkers for Trials of Neuroprotection in Parkinson's Disease
|
Jan 30, 2013 |
|
Parkinson's Disease: Evidence for Environmental Risk Factors
|
Jan 30, 2013 |
|
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
|
Jan 30, 2013 |
|
The Genetics of Parkinson's Disease: Progress and Therapeutic Implications
|
Jan 30, 2013 |
|
Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease
|
Jan 30, 2013 |
|
DYT7 gene locus for cervical dystonia on chromosome 18p is questionable
|
Jan 11, 2013 |
|
Common variation in the LRRK2 gene is a risk factor for Parkinson's disease
|
Jan 11, 2013 |
|
Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations
|
Jan 11, 2013 |
|
Weak detrusor contractility correlates with motor disorders in Parkinson's disease
|
Jan 11, 2013 |
|
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy
|
Jan 11, 2013 |
|
Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease
|
Jan 11, 2013 |
|
Imaging measures predict progression in progressive supranuclear palsy
|
Jan 11, 2013 |
|
Myoclonus and dystonia in cerebrotendinous xanthomatosis
|
Jan 11, 2013 |
|
Atypical parkinsonism and cerebrotendinous xanthomatosis: Report of a family with corticobasal syndrome and a literature review
|
Jan 11, 2013 |
|
The prevalence of primary dystonia: A systematic review and meta-analysis
|
Jan 11, 2013 |
|
Respiratory disorders associated with dystonia
|
Jan 11, 2013 |
|
An electromyographic study of parkinsonian swallowing and its response to levodopa
|
Jan 11, 2013 |
|
Psychogenic facial movement disorders: Clinical features and associated conditions
|
Nov 02, 2012 |
|
Primary lateral sclerosis as progressive supranuclear palsy: Diagnosis by diffusion tensor imaging
|
Jun 22, 2012 |
|
Pseudo-heterozygous rearrangement mutation of parkin
|
Apr 25, 2012 |